JW (Cayman) Therapeutics Co. Ltd (HKG:2126)
Hong Kong · Delayed Price · Currency is HKD 1.800
+0.050 (2.86%)
Jul 10, 2026, 2:11 PM HKT
HKG:2126 Market Cap
HKG:2126 has a market cap or net worth of 710.32 million as of July 9, 2026. Its market cap has decreased by -23.81% in one year.
Market Cap
710.32M
Enterprise Value
442.50M
Revenue
315.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.80
Market Cap Chart
Since November 3, 2020, HKG:2126's market cap has decreased from 8.28B to 710.32M, a decrease of -91.42%. That is a compound annual growth rate of -35.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 710.32M | -30.23% |
| Dec 31, 2025 | 1.02B | 96.55% |
| Dec 31, 2024 | 518.01M | -42.89% |
| Dec 29, 2023 | 907.01M | -47.90% |
| Dec 30, 2022 | 1.74B | -67.36% |
| Dec 31, 2021 | 5.33B | -47.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CANbridge Pharmaceuticals | 1.17B |
| Cutia Therapeutics | 1.02B |
| Cloudbreak Pharma | 1.01B |
| Kintor Pharmaceutical | 1.01B |
| Sunho Biologics | 970.43M |
| Brii Biosciences | 822.86M |
| Wuhan YZY Biopharma | 736.63M |
| Shanghai Bio-heart Biological Technology | 732.69M |